Cleared Traditional

K213031 - Solex 7 Intravascular Heat Exchange Catheter, Cool Line Intravascular Heat Exchange Catheter, ICY Intravascular Heat Exchange Catheter, Quattro Intravascular Heat Exchange Catheter, Start-Up Kit, Coolgard 3000 Console, Thermogard XP Console (FDA 510(k) Clearance)

Dec 2021
Decision
90d
Days
Class 2
Risk

K213031 is an FDA 510(k) clearance for the Solex 7 Intravascular Heat Exchange Catheter, Cool Line Intravascular Heat Exchange Catheter, ICY Intravascular Heat Exchange Catheter, Quattro Intravascular Heat Exchange Catheter, Start-Up Kit, Coolgard 3000 Console, Thermogard XP Console. This device is classified as a System, Hypothermia, Intravenous, Cooling (Class II - Special Controls, product code NCX).

Submitted by Zoll Circulation, Inc. (San Jose, US). The FDA issued a Cleared decision on December 20, 2021, 90 days after receiving the submission on September 21, 2021.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 870.5900.

Submission Details

510(k) Number K213031 FDA.gov
FDA Decision Cleared Substantially Equivalent - Abbreviated 510(k) (SESU)
Date Received September 21, 2021
Decision Date December 20, 2021
Days to Decision 90 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code NCX - System, Hypothermia, Intravenous, Cooling
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.5900